Semaglutide news

All news on Semaglutide: plants, production capacities, investments and involved companies in Europe.

6 May 2013
Novo Nordisk Invests DKK 380 Million in Kalundborg Plant
The investment will create 50 jobs and convert existing facilities for semaglutide production, a new type 2 diabetes treatment. The plant will be operational by Q1 2014.

Who will be producing Semaglutide in the future?

Find out with chemXplore Analytics